Arcellx, Inc. Profile Avatar - Palmy Investing

Arcellx, Inc.

Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical tr…
Biotechnology
US, Gaithersburg [HQ]
Government, Law & Regulation

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Arcellx, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
0.0 IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
YoY Trends
  • No trends presentable at the moment.

Spending By Type

Awards
Obligations
Contracts IDV Contracts Grants Loans Direct Other

Arcellx, Inc. can't present spending by time.

Contract Analysis

There are no contract award details available for Arcellx, Inc.

End of ACLX's Analysis
CIK: 1786205 CUSIP: 03940C100 ISIN: US03940C1009 LEI: - UEI: -
Secondary Listings
ACLX has no secondary listings inside our databases.